Xeris Biopharma Holdings, Inc. (XERS) Analyst Estimates Annual - Discounting Cash Flows
XERS
Xeris Biopharma Holdings, Inc.
XERS (NASDAQ)
Period Ending: 2029
12-31
2028
12-31
2027
12-31
2026
12-31
2025
12-31
2024
12-31
2023
12-31
2022
12-30
2021
12-30
2020
12-30
2019
12-30
2018
12-30
Number of Analysts 3 4 6 5 2 5 2 1 1 2 1 1
Estimated Revenue
Low 520.3 452.2 396.5 332.6 285.8 199.3 165.3 100.8 44.33 20.58 1.4 1.73
Average 571.1 496.4 435.3 368 288.2 201.1 181.4 107.9 47.47 22.03 1.5 1.86
High 665.6 578.5 507.3 425.5 289.4 204 211.4 121 53.21 24.7 1.68 2.08
Estimated EBITDA
Low -378.4 -328.9 -288.4 -241.9 -164.5 -116 -120.2 -68.78 -30.25 -14.04 -0.957 -1.18
Average -324.7 -282.2 -247.5 -209.2 -163.9 -114.3 -103.1 -61.36 -26.99 -12.52 -0.853 -1.05
High -295.8 -257.1 -225.4 -189.1 -162.5 -113.3 -93.95 -57.31 -25.2 -11.7 -0.797 -0.985
Estimated EBIT
Low -412.6 -358.6 -314.5 -263.8 -179.4 -126.5 -131.1 -75.01 -32.99 -15.31 -1.04 -1.29
Average -354.1 -307.7 -269.9 -228.1 -178.7 -124.7 -112.5 -66.92 -29.43 -13.66 -0.931 -1.15
High -322.5 -280.3 -245.8 -206.2 -177.2 -123.6 -102.5 -62.5 -27.48 -12.76 -0.869 -1.07
Estimated Net Income
Low 104.5 65.27 17.7 7.78 -6.48 -57.85 -75.21 -114.5 -206.9 -363.5 -800.7 -947.3
Average 118.2 109.4 61.09 29 -5.43 -53.35 -59.56 -102.5 -178.8 -314.1 -691.9 -818.6
High 143.6 143 98.17 45.58 2.16 -48.85 -54.73 -90.48 -163.4 -287.1 -632.4 -748.3
Estimated SGA Expenses
Low 945.7 822 720.8 604.6 519.5 362.3 300.4 183.2 80.59 37.4 2.55 3.15
Average 1,038 902.3 791.3 669 523.9 365.5 329.8 196.2 86.29 40.05 2.73 3.37
High 1,210 1,052 922.2 773.5 526 370.8 384.3 219.9 96.73 44.89 3.06 3.78
Estimated EPS
Low 0.712 0.445 0.121 0.053 -0.044 -0.394 -0.512 -0.78 -1.41 -2.48 -5.46 -6.45
Average 0.805 0.641 0.371 0.182 -0.022 -0.359 -0.422 -0.674 -1.22 -2.14 -4.71 -5.58
High 0.978 0.974 0.669 0.311 0.015 -0.333 -0.373 -0.616 -1.11 -1.96 -4.31 -5.1
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program